Congenital toxoplasmosis: Difference between revisions

From IDWiki
No edit summary
No edit summary
Line 4: Line 4:
**However, it is possible to acquire from reactivation of latent toxoplasmosis in an HIV-infected mother
**However, it is possible to acquire from reactivation of latent toxoplasmosis in an HIV-infected mother
*Risk of transplacental infection of fetus is lowest in first trimester and highest in third
*Risk of transplacental infection of fetus is lowest in first trimester and highest in third
**First trimester: 10%
**Second trimester: 25%
**Third trimester: 80%
*See also [[toxoplasmosis in pregnancy]]
*See also [[toxoplasmosis in pregnancy]]



Revision as of 12:04, 20 September 2020

Background

  • Can be acquired during maternal parasitemia associated with primary infection
    • However, it is possible to acquire from reactivation of latent toxoplasmosis in an HIV-infected mother
  • Risk of transplacental infection of fetus is lowest in first trimester and highest in third
    • First trimester: 10%
    • Second trimester: 25%
    • Third trimester: 80%
  • See also toxoplasmosis in pregnancy

Clinical Manifestations

Diagnosis

  • Standard workup starts with serology, then adds PCR and other investigations if clinical suspicion is high
  • Serology: in neonates, IgG serology reflects maternal status, so use IgM and IgA instead
  • Molecular testing: if clinical suspicion is high, add PCR of the peripheral blood, urine, and CSF to the serology
  • If clinical suspicion is high, also get ophthalmologic evaluation, hearing assessment, ultrasound or CT of the brain, and lumbar puncture

Management

  • Postnatal treatment of neonates is with standard therapy for at least 12 months
  • Treatment of congenital infection in older children is standard therapy until 1 to 2 weeks after resolution of signs or symptoms
    • Pyrimethamine 1 mg/kg q12h (max 50 mg) for 2 days, followed by 1 mg/kg/day (max 25 mg)
    • Sulfadiazine 75 mg/kg load, followed by 50 mg/kg q12h (max 4 g/day)
    • Folinic acid 10-20 mg po thrice weekly
    • Can add prednisone for severe chorioretinits at 1 mg/kg/day divided bid (max 40 mg/day), followed by a rapid taper
  • Serial evaluations with a clinical assessment, neuroradiology, ophthalmology, and CSF analysis
  • For prevention, refer to the management of toxoplasmosis in pregnancy

References

  1. ^   Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. The Lancet. 2007;369(9556):115-122. doi:10.1016/s0140-6736(07)60072-5.